- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Anges Inc.
Industry Sector: HealthTechnology
CEO: N/A
Number Of Employees: 55
Enterprise Value: $70,683,267
PE Ratio: -0.67
Exchange/Ticker 1: Tokyo:4563
Exchange/Ticker 2: N/A
Latest Market Cap: $98,267,895
BioCentury | Mar 19, 2024
Deals
Deals Report: AZ buys Amolyt for Phase III asset, Novartis takes out IFM Due
Plus: Merck gains access to Pearl Bio’s synthetic biology platform for up to $1B, Hansoh partners with Biotheus on bispecific ADCs, and more
BioCentury | Jan 27, 2022
Data Byte
Plasmid-based gene therapies – a small but growing pipeline
An old method makes a comeback
BioCentury | Oct 19, 2021
Discovery & Translation
CRISPR innovation hits the gas
A burst of research is radically expanding tools to optimize CRISPR therapies and access new targets
BioCentury | Dec 16, 2020
Deals
Dec. 15 Quick Takes: Singlera raises $150M for cancer dx; plus AnGes-Emendo, Entresto, vTv and Unity
Cancer screening play Singlera raises megaroundSinglera Genomics Inc. raised $150 million in a series B round led by the CICC Kai Tak Innovative Biomedicine Fund, and co-led by Detong Capital and
Items per page:
1 - 6 of 6